# Ultralow Dose PET Imaging for PSMA Expression

> **NCT06904313** · PHASE2 · RECRUITING · sponsor: **Akiva Mintz** · enrollment: 200 (estimated)

## Conditions studied

- Healthy Volunteer
- Prostate CA

## Interventions

- **DRUG:** Piflufolastat F18

## Key facts

- **NCT ID:** NCT06904313
- **Lead sponsor:** Akiva Mintz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-12
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06904313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06904313, "Ultralow Dose PET Imaging for PSMA Expression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06904313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*